CEO Roundtable on Cancer, Inc.

In 2001, former President George H.W. Bush asked Robert A. Ingram, then the CEO of GlaxoWellcome, to form an organization comprising action-oriented chief executives and challenged them to “do something bold and venturesome about cancer within your own corporate families.

President Bush also requested that Dr. Martin J. Murphy take the role as Founding CEO of the Roundtable on Cancer, a position that he held until January 2020.

Today, the CEO Roundtable on Cancer, Inc., chartered as a 501(c)(3) nonprofit organization, works to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to the best available treatments, and hasten the discovery of novel and more effective anti-cancer therapies to help eliminate cancer as a personal disease and public health problem.

Two ways the CEO Roundtable on Cancer is advancing this vision is with the CEO Cancer Gold Standard™, an employer-led, wellness accreditation program addressing prevention, diagnosis and quality treatment of cancer, and with the CEO Roundtable on Cancer-China, a non-governmental organization (NGO), bringing this employer-led health and wellness model to China.

Each November, the CEO Roundtable on Cancer convenes its annual meeting at SAS headquarters in Cary, NC. In 2018, at CEO Roundtable VXII, Project Data Sphere held a first-ever breakout session as part of the meeting, giving attendees the option of learning more about PDS' myriad collaborations, research programs, and platform enhancements.

CEO Roundtable on Cancer Board of Directors
Robert Bradway
Robert Bradway
Chairman
Chairman and Chief Executive Officer, Amgen
K. Andrew Crighton
K. Andrew Crighton
Board Member
Chief Executive Officer, CEO Roundtable on Cancer and Project Data Sphere®
Joaquin Duato
Joaquin Duato
Board Member
Vice Chairman of the Executive Committee, Johnson & Johnson
Robert Ingram
Robert Ingram
Founding Chairman
General Partner, Hatteras Venture Partners
Martin J. Murphy
Founding Board Member
CEO and Co-founder, CEO Roundtable on Cancer - China
Christopher Viehbacher
Christopher Viehbacher
Immediate Past Chairman
Managing Partner, Gurnet Point Capital

Life Sciences Consortium

Formed under the CEO Roundtable on Cancer in 2005, the Life Sciences Consortium (LSC) brings together oncology pharmaceutical/ biotechnology companies to enable research and development to deliver more effective oncology therapies to patients faster. This collaboration focuses on solving issues common to companies engaged in cancer drug discovery and development that cannot be solved by any company alone. The LSC was given three directives:

  • Improve clinical trial delivery
  • Help streamline the regulatory process
  • Create a pre-competitive pool of intellectual property that all may use for discovery and development

The mission of the LSC is threefold:

  • Be collaborative and catalytic
  • Accomplish together what no single company might consider alone
  • Provide safe and effective new medicines …  faster
Life Sciences Consortium Task Force
David Reese
David Reese
Co-Chairman
Executive Vice President of Research and Development, Amgen
Mace Rothenberg
Mace Rothenberg
Co-Chairman
Chief Medical Officer, Pfizer